Inside Solid Tumor Therapies with BlueSphere Bio’s CEO Dr. David Apelian
Mar 17, 2022•25 min•Season 1Ep. 19
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
We love to hear from our listeners. Send us a message.
BlueSphere Bio's CEO Dr. David Apelian explains the difficulties associated with treating solid tumor cancers as well as what the CGT sector needs to get right in the short term and why.
For the best experience, listen in Metacast app for iOS or Android